Express Pharma - Page 403 of 2181 - Express Pharma

Lupin receives US FDA approval for Dapagliflozin tablets

Inventia enters the U.S. market with FDA approved Dapagliflozin tablets

Biocon launches Bosaya and Aukelso in the United States

By 2023, pharma industry is expected to be worth more than $1 trillion

The power of AI is the future of pharma

Post the COVID-19 pandemic, pharma industry has introduced new focus areas

SMART programme for Ayurveda professionals to boost R&D in Indian Ayurveda

Digital age requires new concepts and methods to compete in business and support economy

It’s crucial to serialise the smallest usable unit of a pharma product, a distinct identity

Pharma Playbook 2023

Nutra industry’s healthy turnaround in 2022 and expected roadmap towards future

Persistent partners with Microsoft to accelerate its growth

Nasal spray development and characterisation